This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Pulmocide Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Christopher John Wallis - Innovator in Antifungal Compounds
Introduction
Christopher John Wallis is an inventor based in London, GB. He is currently associated with Pulmocide Limited, where he contributes to the development of innovative solutions in the field of antifungal compounds. Despite having no granted patents to his name, Wallis is actively involved in research and development.
Latest Patent Applications
Wallis's notable patent application is titled "Polymorphs of Triazole Antifungal Compound PC945." This invention relates to crystalline polymorphic manifestations of a compound of formula (I) and explores related aspects of its application.
Conclusion
Christopher John Wallis is a dedicated inventor working on advancements in antifungal treatments, showcasing his commitment to innovation in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile